Lhasa Limited shared knowledge shared progress



8 December 2020

Webinar - Harmonising compound-specific exposure limits for pharmaceutical impurities: Lhasa Limited’s AI/PDE Data Sharing Project


Lhasa Webinar

Lhasa Limited Senior Scientist, David Wilkinson and Principal Global Alliance Manager, William Drewe discussed Lhasa's AI/PDE data sharing project.

Initiated in 2017 Lhasa’s AI/PDE Data Sharing Project brings together domain experts from leading pharmaceutical organisations to collaborate through sharing and harmonising compound-specific exposure limits (i.e. acceptable intakes (AIs), or permissible or permitted daily exposures (PDEs)). This webinar provided an update on the progress which this project has made to date focusing on topics including:

  • Why it is valuable to collaborate to harmonise AI/PDE limits and the methodology used to derive these
  • Who is involved and how the collaboration works
  • An update on AI/PDE limit data sharing and harmonisation
  • Regulatory perspectives of this project
  • Feedback from members involved in this project
  • How other members of Lhasa can join this collaborative data sharing project
  • Headline Event (shown first above featured)

  • Featured Event

Related Publications

Back to events

© 2022 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.